Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High – Here’s Why

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $87.57 and last traded at $86.78, with a volume of 270394 shares traded. The stock had previously closed at $85.73.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded shares of Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Two investment analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, the company has an average rating of “Strong Buy”.

Sandoz Group Price Performance

The firm has a fifty day moving average of $77.82 and a two-hundred day moving average of $68.48. The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.